Fate Therapeutics Reports Second Quarter 2015 Financial Results

Go back to Fate Therapeutics Reports Second Quarter 2015 Financial Results
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 2.57 --0 (-0%)
Previous Close $2.57    52 Week High $4.76 
Open $2.57    52 Week Low $1.46 
Day High $2.57    P/E N/A 
Day Low $2.57    EPS $-1.91 
Volume 86